Answers are grounded in this paper and cite their sources.
MOTIVATION: Drug-target affinity prediction is pivotal in drug discovery. However, most existing computational methods focus primarily on binding affinity and do not explicitly model dissociation kinetics (Koff). Accurately predicting Koff therefore remains both important and challenging for kinetics-guided drug screening and residence-time optimization. RESULTS: To address this challenge, we propose MGCA, a multi-granularity cross-attention framework for Koff prediction. MGCA represents proteins using multi-depth ESM2 features and ligands using multi-radius Morgan fingerprints. It integrates these representations through gated expert fusion, low-rank bidirectional cross-attention, and protein-anchored residual fusion. Across the Zhao dissociation-kinetics dataset and the KinetX benchmark, MGCA achieved the lowest mean squared error (MSE) in all warm-start and protein cold-start evaluations. Notably, MGCA reduced protein cold-start MSE by 42.5% and 12.1% relative to the recent kinetics-specific BiCoA-Net model on Zhao and KinetX, respectively. Under matched hardware, MGCA also trained substantially faster than BiCoA-Net and MoE-Kinetic. Ablation and case-study analyses further showed that MGCA effectively integrates protein, ligand, and interaction information, supporting cross-target generalization, within-target compound ranking, and feature-level interpretation. Together, these results establish MGCA as an accurate, efficient, and interpretable framework for protein-ligand dissociation kinetics prediction. AVAILABILITY AND IMPLEMENTATION: The source code and datasets are available at https://github.com/CSUBioGroup/MGCA-koff and https://doi.org/10.5281/zenodo.22932383.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: